drugset / Trial / NCT05199714
A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes
Completed
12 enrolled
McGill University Health Centre/Research Institute of the McGill University Health Centre
Juvenile Diabetes Research Foundation · collab
RandomizedCrossoverOpen-labelTreatment
Summary
The investigators aim to assess the glycemic outcomes of a fully automated insulin-and-pramlintide artificial pancreas and a comparator insulin-alone artificial pancreas with carbohydrate matched boluses.
Timeline
- Start
- 2022-02-21
- Primary completion
- 2023-03-25
- Completion
- 2023-03-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramlintide | Peptide | 8 ug | — |
| Subject | Pramlintide | Peptide | 10 ug | — |
| Subject | insulin aspart | Protein / enzyme biologic | — | — |